ReviewCancer Cell2020

Challenges and Opportunities for Pancreatic Cancer Immunotherapy.

DOI 10.1016/j.ccell.2020.08.004 ↗ OpenAlex, retrieved 5 November 2026

Journal: Cancer Cell
Published: 17 September 2020
Citations: 534
Type: Review

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Trials 2

BackgroundFecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metas… NCT07854977 ↗
BackgroundCombined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma NCT05955157 ↗

Grants 4

Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients P01CA210944 ↗
Cancer Therapeutics Program P30CA016520 ↗
Immunobiology and immunotherapy of pancreatic cancer R01CA169123 ↗
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer R01CA229803 ↗